Invest with Jenny Rooke
Deals Last 12 Months
Unique LPs have invested
Note from Jenny Rooke
Visionary startups developing innovative life science technologies with the greatest potential often struggle to raise capital from traditional funders. These companies are typically multi-disciplinary (e.g. genomics + optics + microfluidics + big data) and/or market-making, and don't neatly fit VCs' patterns and boxes. I stand in this gap and capitalize on this need. I have an affinity for these early-stage, category-defying innovators; I take the time to understand their science and technology, applications and markets, and try to help them achieve their full potential. I believe in the enormous and relatively untapped possibilites of life science technologies and discoveries as applied to realms outside of healthcare, and in the unbounded potential of the entrepreneurial visionaries who will lead us in realizing these possibilities.
Leading life science technology deals with hardware and big data elements. Focus on platforms, tools, molecular diagnostics, direct-to-consumer, and synthetic biology. Specialize in non-healthcare commercialization of innovative life science technologies e.g., scientific research, industrial biotech, consumer products. Companies require dramatically less capital to exit than traditional biotech deals.